Clinical Trials Logo

Clinical Trial Summary

This is a study supported by Duke Sports Cardiology and Duke Sports Medicine with the intent to enhance the cardiovascular screening of collegiate athletes from a regional to nationally recognized program to understand and eventually reduce cardiovascular events in athletes. The data from this ongoing registry will be used to better understand, refine, and improve the current cardiovascular Duke Athlete Screening process and use this experience as a role model to expand across the ACC.


Clinical Trial Description

The purpose of this study is to screen for and determine the prevalence of structural, functional, or electrophysiologic cardiac abnormalities in a population of young athletes using bedside cardiac ultrasound, electrocardiogram (ECG) and a physical exam.

The investigators will attempt to answer the question regarding the feasibility of screening all collegiate athletes with bedside cardiac ultrasound, ECG, and history/physical exams results in a higher sensitivity for abnormalities than screening using ECG and physical exams alone. The investigators will also analyze the cost and cost effectiveness of screening the young athlete population with bedside cardiac ultrasound. Costs will be calculated to include the amount of dollars spent on equipment, gels, and other supplies, but will not include the cost of performing the bedside cardiac ultrasound, which will be assumed as part of the physical exam. Additionally, the investigators will be gathering a number of data markers from the bedside cardiac ultrasound, including but not limited to right ventricular and left ventricular cavitary size, septal wall thickness, free ventricle wall on RV, and free ventricle wall on LV, in evaluation of the athlete's heart. The importance of these measurements is for the continued knowledge and data set analysis collection as there is limited known athletic cardiac measurements. There is minimal risk involved in this study. The investigators believe that by adding bedside cardiac ultrasound to the history, physical, and ECG, it will increase the sensitivity and specificity of screening for these life-threatening abnormalities in young athletes, and reduce the morbidity and mortality associated with these conditions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03150940
Study type Observational
Source Duke University
Contact
Status Completed
Phase N/A
Start date May 8, 2017
Completion date July 30, 2017

See also
  Status Clinical Trial Phase
Completed NCT03288623 - The Effects of Dark Chocolate Implementation in Elite Athletes N/A
Completed NCT03656861 - Lithuanian Atletes' Aortic Diameter
Completed NCT02568072 - Training-induced Increased Left Ventricular Trabeculation
Recruiting NCT03049995 - Stress Echo 2020 - The International Stress Echo Study
Completed NCT03612063 - Accuracy of Commercially Available Heart Rate Monitors in Athletes N/A
Recruiting NCT03025737 - Semmelweis Sport Study N/A
Completed NCT04738877 - Cardiovascular Effects of Marathon Running
Active, not recruiting NCT04147299 - Cardiopulmonary and Right Ventricular Function in Health and Disease
Completed NCT03992677 - Feasibility of Improving Risk Stratification in Brugada Syndrome
Completed NCT04726150 - Effect of CoVid-19 (CoronaVirusDisease-19) and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias